Your blog category
The Nifty IT index has entered a bear market, but most companies continue to command valuations above the sector’s own multiple. What’s driving this trend and what does it mean for Indian investors?
Morgan Stanley says Trump’s plan to impose 100% tariffs on imported branded and patented pharmaceuticals may not significantly impact Indian companies, except for those with specialty drug exposure like Sun Pharma.
Laurus Labs Ltd. does not anticipate any significant implications of the US tariff of 100% on branded or patented pharmaceutical products, according to a top executive.
The Nifty 50 and Sensex ended lower for six sessions in a row, posting the worst week since March. Get the latest updates and analysis on the Indian stock market.
Poly Medicure’s recent acquisition of Italy-based Citieffe Group is a strategic move to strengthen its presence in the high-value medical device space. Here’s what it means for Indian investors and the company’s future prospects.
Welspun Corp Ltd has received a fresh order worth Rs 1,600 crore from the Middle East, taking its global order book to nearly Rs 18,000 crore. What does this mean for Indian investors?
The Indian stock market witnessed a significant decline on Friday, with the Sensex and Nifty hitting three-week lows. We explore the reasons behind this downturn and examine if small and mid caps offer buying opportunities for investors.
US President Donald Trump’s announcement of a 100% tariff on branded and patented pharmaceutical drugs may have far-reaching consequences for Indian drugmakers and US consumers alike.
The NSE Nifty 50 benchmark has slipped 5.5% from its all-time high a year ago. What does this mean for your trading strategy? Find out how to navigate the current market conditions.
The Indian stock market suffered its worst weekly fall in nearly eight months. What led to this decline and which stocks defied the market rout? Get the latest updates and insights.